The concomitant appearance of glomerular collapse and enlargement is characteristic of the histological findings in nephrosclerosis. However, no previous study quantitatively examined the clinicopathological significance of this feature in patients with biopsy-proven nephrosclerosis.
Nephrosclerosis is one of the renal diseases that can occur with aging and hypertension. [1] [2] [3] [4] A definitive diagnosis of nephrosclerosis requires the confirmation of typical pathological features, including moderate to severe intrarenal vascular lesions, along with glomerulosclerosis, interstitial fibrosis, and tubular atrophy, with the exclusion of other underlying or concomitant renal disease. 5, 6 Not all patients with nephrosclerosis are considered for renal biopsies, particularly if they present an indolent clinical course, such as a mild urinary abnormality and slowly progressive renal functional decline, without suspicion of other renal disease. Despite the potential existence of huge numbers of patients with nephrosclerosis, only a limited number of biopsy specimens are available. Thus, the significance of histopathological findings to the renal outcomes for nephrosclerosis patients remains unclear.
Previous studies reported that glomerular collapse is one of the typical histological features in patients with nephrosclerosis. 1, [7] [8] [9] The term "glomerular collapse" is often used to describe glomeruli with mild to moderate shrinkage or decreased volume of the capillary tufts, but this is based on relative and subjective judgment by observers. In this study, we quantified morphological parameters of the renal corpuscle by estimating glomerular tuft volume (GV) and Bowman capsule volume (BV) from cross-sections of renal biopsies. We hypothesized that an imbalanced volume ratio, namely, a decrease in the ratio of GV to BV (G/B ratio), can be applied to evaluate glomerular collapse or ischemia, which may be attributed to decreased glomerular perfusion. This study therefore examined the significance of the G/B ratio as a clinical feature at the time of diagnostic biopsy to the long-term renal outcomes of patients with biopsy-proven nephrosclerosis.
and Daisan Hospital. The principal indication for renal biopsy was persistent proteinuria and/or renal function decline. Nephrosclerosis was diagnosed based on the typical histopathological features in biopsies, such as moderate to severe intimal thickening of arteries and/or arteriolar hyalinosis. 5, 6 The exclusion criteria were (i) advanced renal function decline, defined as estimated glomerular function (eGFR) <30 ml/min/1.73 m 2 ; (ii) a history of acute kidney injury at the time of renal biopsy, including those with typical clinicopathological features of malignant or accelerated hypertension; (iii) a diagnosis of any other concurrent renal or systemic disease, in particular immunoglobulin A (IgA) nephropathy, diabetic nephropathy, or lupus nephritis; (iv) fewer than 5 renal corpuscles that could be evaluated for measurement 10 ; and (v) less than 1 year of follow-up after renal biopsy. Patients exhibiting major renal functional declines were excluded because such patients were assumed to already suffer from chronic advanced lesions, creating a vicious cycle of progression regardless of other clinicopathological factors. This study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the ethics review board of the Jikei University School of Medicine (29-350 [8,966] ). All patients included in this study provided their written informed consent for performing the renal biopsy. Patients were told that they could withdraw permission for use of their data at any time.
Clinical data collection
Clinical data were obtained during admissions for renal biopsy. The eGFR was calculated by applying a modified 3-variable equation for estimating the GFR for Japanese patients 11 : 
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where s-Cre is the serum creatinine level. Urinary protein excretion was measured after 24-hour urine collection. Renal events were defined as (i) the doubling of serum creatinine (DSC) and (ii) the initiation of renal replacement therapies (end-stage renal disease (ESRD)). The annual absolute and percentage eGFR changes during the observation period were also recorded. The patients were followed from the time of renal biopsy until the time of each renal event, or until death, or until the end of follow-up in March 2017.
Histopathological analyses
All renal tissue specimens were obtained via percutaneous needle biopsies. All specimens were examined by light microscopy and immunohistochemistry, including staining for IgG, IgA, IgM, C3, and C1q, and electron microscopy. Renal histopathological findings, including global glomerulosclerosis, segmental glomerulosclerosis, interstitial fibrosis/tubular atrophy, and the grade of arterial lesions, were evaluated as previously described. 9, 12 Glomerular density (the number of glomeruli per unit of cortical area) was calculated as previously described. 9 Bowman capsules without glomerular tufts and glomeruli with periglomerular fibrosis were assessed and counted. The grade of preglomerular arterioles was semiquantitatively evaluated based on the proportion of arteriolar arteries exhibiting hyalinosis, as follows: grade 0 (G0), no hyalinosis of the vessel wall; grade 1 (G1), hyalinosis of less than a quarter of the circumference; grade 2 (G2), hyalinosis of a quarter to a half of the circumference; and grade 3 (G3), hyalinosis involving more than half of the circumference of the vessel wall. 13 Based on this grading system, the mean grade of renal arteriolar hyalinosis (the arteriolar hyalinosis index) was calculated. [14] [15] [16] The mean glomerular tuft area (GA) and mean Bowman capsule area (BA) were defined as previously described. 17 All renal corpuscles were analyzed in cross-sections of biopsy specimens, excluding (i) corpuscles with glomeruli affected by global glomerulosclerosis and (ii) corpuscles for which the outer loops of glomerular tufts or the inner loops of Bowman capsules could not be defined. Glomeruli exhibiting global glomerulosclerosis, whether of the ischemia-based obsolescent or solidified type, will ultimately be absorbed. This degenerative process is accompanied by a series of nonspecific changes, including periglomerular fibrosis and the complete disappearance of the Bowman space. These changes strongly bias glomerular size metrics. Thus, we excluded glomeruli exhibiting global glomerulosclerosis. Glomeruli exhibiting segmental glomerulosclerosis were included if the loops were more or less definable.
Each glomerular tuft area was defined as the area of the outer side of the capillary loop of the glomerular tuft ( Figure 1a ). Each Bowman capsule area was defined as the area of the inner side of the glomerular parietal epithelial cell layers (Figure 1b) . The GA and BA were measured using computerized image analysis (Leica IM500; Leica Microsystems, Germany) and calculated by averaging all measured areas of the glomerular tufts and Bowman capsules. The GV and BV were calculated from the GA and BA, respectively, using the following Weibel and Gomez equations:
where β is a dimensionless shape coefficient (β = 1.38 for sphere), d is a size distribution coefficient that is used to adjust for variations in glomerular size, and fi is a coefficient that is used to adjust for specimen shrinkage induced by immersion fixation. Our analysis used values for d = 1.01 and fi = 0.85, as in previous studies. [18] [19] [20] The G/B ratio was defined as the ratio of GV to BV. 17 
Statistical analyses
Continuous variables are expressed as means ± SD. For comparisons between 2 groups, Student's t-tests, MannWhitney U-tests, or chi-squared tests were used, as appropriate. Survival time curves for the incidence of DSC and ESRD were compared using log-rank tests. Cox hazard regression analyses of the incidence of DSC were performed to determine the effects of pathological variables. The explanatory variables included were clinical factors considered relevant to renal outcomes. A value of P < 0.05 was considered significant for all statistical tests. Data were analyzed using SPSS software, ver. 23 (IBM, Armonk, NY), and GraphPad PRISM 5J (GraphPad Software, La Jolla, CA).
RESULTS

Clinicopathological characteristics at the time of renal biopsy in patients with nephrosclerosis
We initially identified 112 patients with an eGFR ≥30 ml/ min/1.73 m 2 and a histological diagnosis of benign nephrosclerosis in our renal biopsy archives. Patients whose biopsy 466. She presented with persistent proteinuria, together with previously undiagnosed hypertension, at the time of renal biopsy. She had no history of smoking or family history of renal disease. Primary and secondary renal diseases other than nephrosclerosis were excluded via detailed immunohistochemical analyses and electron microscopy. She was treated with a combination of ACEI and ARB after diagnosis with the aid of renal biopsy data. After 8.2 years of observation, she developed renal dysfunction with a DSC, and an eGFR of 34 ml/min/1.73 m 2 . Periodic acid-methenamine silver stain. Bar = 100 μm. Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; DSC, doubling of serum creatinine levels; eGFR, estimated glomerular filtration rate; G/B ratio, volume ratio of glomerular tufts to Bowman capsules. specimens contained fewer than 5 renal corpuscles (n = 25) or whose files included less than 1 year of follow-up after renal biopsy (n = 20) were excluded. Ultimately, the data from 67 patients with nephrosclerosis were analyzed in this study.
The clinicopathological characteristics of 67 patients with nephrosclerosis at the time of renal biopsy are shown in Table 1 . All the patients were Japanese. Representative examples of area measurements for glomerular tufts and Bowman capsules are shown in Figure 1a ,b. In this cohort of patients with biopsy-proven nephrosclerosis, GV and BV varied by up to 7.9-fold and 6.0-fold among the individuals, respectively.
The G/B ratio varied among individuals and ranged from 0.302 to 0.757, with a median value of 0.615. To examine clinicopathological findings associated with the G/B ratio, we compared the characteristics of patients with high and low G/B ratios, divided into 2 groups by the median value (Table 1) . Clinical variables, including age, renal function, urinary protein excretion, and blood pressure status, were almost comparable between the groups. Histopathological findings, including the number of evaluated renal corpuscles, Bowman capsules without glomerular tufts, glomerular density, glomerular lesions, tubulointerstitial lesions, and vascular lesions, were similar in both groups. The GV values in patients with higher G/B ratios were significantly larger than those in patients with lower G/B ratios, while the BV values were similar in both groups. Of the 67 patients with nephrosclerosis included in this study, 36 (54%) had preserved renal function at the time of biopsy, with an eGFR of more than 60 ml/min/1.73 m 2 . Within this subgroup, clinicopathological findings were comparable between patients with high and low G/B ratios (Supplementary Table 1 ). We also compared clinicopathological findings between patients below and above the median values of GV or BV. Lower values for both GV and BV were associated with higher rates of segmental sclerosis and tubulointerstitial lesions, whereas clinical variables such as age, renal function, urinary protein excretion, and blood pressure status were almost comparable between these groups (Supplementary Table 2 ).
The predictive significance of G/B ratio for long-term renal outcomes
Representative renal histopathological findings from patients with high and low G/B ratios are shown in Figure 1c ,d, respectively. To determine the predictive significance of the G/B ratio in terms of long-term renal outcomes for nephrosclerosis patients, we examined the association between the G/B ratio and renal outcome indices, including DSC and ESRD. Overall, 25 (37%) progressed to DSC and 9 (13%) to ESRD, over a median follow-up period of 7.8 and 8.5 years, respectively. Renal survival curve analyses indicated a significantly worse renal prognosis for patients with a low G/B ratio, relative to those with a high G/B ratio (Figure 2a,b) . Similar results were obtained in patients with preserved renal function (with an eGFR of more than 60 ml/ min/1.73 m 2 at the time of biopsy diagnosis) (Figure 2c,d) . In contrast, the simple metrics of either GV or BV alone were not associated with survival for either of the renal outcome measures (Figure 3a-d) . The annual absolute eGFR changes in patients with lower G/B ratios tended to be larger than those in patients with higher G/B ratios (-3.1 ± 2.5 ml/ min/1.73 m 2 /year vs. -2.3 ± 1.7 ml/min/1.73 m 2 /year, P = 0.169), although statistical significance was not attained. The annual percentage eGFR change exhibited similar trends (-5.1 ± 3.9%/year vs. -3.8 ± 3.1%/year, P = 0.136).
In the Cox regression analyses, a low G/B ratio was significantly associated with DSC, after adjustment for clinical factors such as age, renal function, and proteinuria (Table 2) . On the other hand, neither low GV nor low BV was significantly associated with the incidence of DSC in models using the same clinical factors as explanatory variables (Table 2) .
DISCUSSION
The concomitant appearance of glomerular collapse and enlargement is a common histological feature in patients with nephrosclerosis. 1, [7] [8] [9] Such heterogeneous distribution of changes in glomerular morphology in nephrosclerosis may be attributed to divergent distribution of the arterial lesions and intrarenal arteriolar perfusion, due to long-term exposure to hemodynamic stress. 21, 22 We posited that glomerular morphological parameters, such as GV, BV, or G/B ratio, were involved in the pathogenesis of nephrosclerosis and thus associated with long-term renal outcomes. To examine this hypothesis, we retrospectively reviewed the clinicopathological features of patients with biopsy-proven nephrosclerosis. Our current results show that low G/B ratios at the time of diagnostic biopsy were significantly associated in survival curves with poor renal outcomes, including DSC and ESRD. In contrast, renal survival analyses based on simple size metrics of renal corpuscles, such as GV and BV, did not show such an association.
Only a few reports have assessed GV and BV in the same study with human subjects. 17, 23 A previous study using a stereological method found that GV was strictly correlated with BV in an autopsy series without apparent kidney disease. 23 Consistent with this observation, we have recently shown that GV was tightly correlated with BV in biopsy specimens from living kidney donors, using the same Weibel and Gomez method as was used in the present study. 17 Of note, in subjects with relatively healthy kidneys, the G/B ratio was not affected in several clinical settings associated with a substantial increase in hemodynamic stress, including older age, obesity, and hypertension. 17 These results indicate that, in healthy kidneys, there may be an optimal, physiologically suitable volume ratio that achieves the most effective filtration in the glomeruli.
To the best of our knowledge, this is the first reported study to have examined the G/B ratio in patients with chronic renal impairment. We found that a lower G/B ratio in patients with nephrosclerosis was associated with worse renal outcomes, whereas BV or GV alone was not. This suggests the importance of a balanced volume ratio between glomerular tufts and Bowman capsules, but not of the absolute value of each metric, in the maintenance of glomerular hemodynamics. Previous studies have suggested that glomerular enlargement is associated with worse renal outcomes in patients with primary glomerulopathies. 24, 25 However, glomerular enlargement is essentially considered to be a compensatory response to maintain GFR. 20, 26, 27 On the other hand, there have been a very limited number of reports showing that an acquired decrease in glomerular size (glomerular collapse) is associated with a poor prognosis. A previous study indicated that the presence of qualitatively evaluated collapsed glomeruli was associated with poor renal outcomes in patients with nephrosclerosis. 28 Our study is unique in quantitatively calculating a G/B ratio, defined as the ratio of GV to BV. A major advantage in measuring G/B ratio may be that it will enable us to distinguish different stages of glomerular injury, identifying normally functioning and functionally abnormal glomeruli. Although they are similar in term of GV values, the ratio may detect glomerular hemodynamic changes, including collapse or ischemia, by alterations in Bowman capsule size.
Older age and renal function decline have been associated with severe renal injury in nephrosclerosis. [29] [30] [31] [32] However, our preliminarily analyses found that none of these clinical factors was associated with G/B ratio (data not shown). The prognostic value of the G/B ratio remained significant in the subgroup of patients with preserved renal function. These results suggest that the mechanisms underlying the reduced G/B ratio are independent of the already reported clinical risk factors for the progression of nephrosclerosis and that a low G/B ratio is not simply a result of renal impairment. [29] [30] [31] [32] We previously reported that the glomerular density (an indicator of nephron mass) of nephrosclerosis patients with overt proteinuria was significantly lower than that of nephrosclerosis patients with mild proteinuria. 9 This indicates that the level of urinary protein excretion in nephrosclerosis patients is, at least in part, associated with glomerular hyperfiltration. However, in our current cohort, neither the urinary protein excretion rate nor the glomerular density was associated with the G/B ratio, indirectly supporting our hypothesis that the G/B ratio determines the renal outcomes in nephrosclerosis patients via a mechanism distinct from that or those causing massive proteinuria or reducing glomerular density. We therefore speculate that a lower G/B ratio may reflect glomerular hypoperfusion and/or abnormalities in tubular urinary flow. Further studies are needed.
The dilation of afferent arterioles with hyalinosis has been identified as an important histopathological finding in the development of impaired renal blood flow and glomerular hyperfiltration. 7 In this study, we did not find a significant association between G/B ratio and other indices of intrarenal vascular lesions. This may be attributed to the fact that the evaluation of vascular lesions has several limitations, including the issue of sampling bias and the possibility of asymmetrical correlation between morphological changes and the degree of functional disorder. 7 Chronic lesions, including global or segmental glomerulosclerosis, periglomerular fibrosis, and interstitial fibrosis/ tubular atrophy, are common histopathological features in nephrosclerosis, 2,6 none of which was associated with G/B ratio in the present study. These findings exclude the possibility that obstructed tubules, leading to so-called atubular glomeruli, 33 are the only mechanism explaining reduced G/B ratios in our cohort. Furthermore, the number of Bowman capsules without identifiable glomerular tufts was comparable between the case groups on either side of the median G/B ratio, excluding the possibility that the G/B ratio was overestimated in the patient group with a high G/B ratio due to a histopathological sampling artifact. However, it should be noted that these results were derived only from observations at the time of initial diagnostic biopsy. To elucidate factor(s) associated with the G/B ratio, observations that encompass longitudinal changes in the ratio, together with other pathological findings, are needed; Multivariate models were adjusted for age, urinary protein excretion >1 g/day, and eGFR <60 ml/min/1.73 m 2 . Abbreviations: BV, Bowman capsule volume; CI, confidence interval; G/B ratio, volume ratio of glomerular tufts to Bowman capsules; GV, glomerular capillary volume; HR, hazard ratio.
analyzing repeated biopsy specimens from the same individuals would be helpful.
This study has several limitations. First, it has a retrospective design and a relatively small sample size, which might have influenced its statistical power. In fact, we could not perform a Cox hazard analysis for the incidence of ESRD due to the limited number of patients that reached this endpoint. Second, in our measurement method, we averaged all cross-sectional areas observed on each specimen and thus did not determine the variability among renal corpuscles within individuals, as was previously reported in the measurement of glomerular tuft size. 34 Third, sampling bias is a critical limitation of needle biopsies; these harvest only small amounts of kidney tissue and thus small numbers of corpuscles. We analyzed at least 5 renal corpuscles per biopsy specimen. However, bias may still have occurred given the limited number of glomeruli retrieved. Also, the G/B ratio differs substantially between different cortical regions within the same kidney. Fourth, we did not directly measure renal hemodynamic parameters and thus could not assess a possible involvement of decreased glomerular perfusion in the imbalanced volume ratio of the renal corpuscles. Finally, we are unable to propose interventions to address a reduction in G/B ratio because the clinically and histopathologically identifiable factor(s) that are associated with the ratio are unknown at present.
In conclusion, our results suggest that the volume ratio of glomerular tufts to Bowman capsules in diagnostic biopsies is associated with long-term renal outcomes in patients with nephrosclerosis. Although the mechanisms underlying an imbalanced volume ratio remain unclear, our results suggest that quantitative evaluation for such subtle morphological changes in renal corpuscles may be useful to predict the subsequent clinical course of patients with nephrosclerosis.
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